| Literature DB >> 28115246 |
Suzanne J Bakewell1, Adam Carie2, Tara L Costich2, Jyothi Sethuraman2, J Edward Semple2, Bradford Sullivan2, Gary V Martinez3, William Dominguez-Viqueira3, Kevin N Sill2.
Abstract
Nanoparticle drug carriers hold potential to improve current cancer therapy by delivering payload to the tumor environment and decreasing toxic side effects. Challenges in nanotechnology drug delivery include plasma instability, site-specific delivery, and relevant biomarkers. We have developed a triblock polymer comprising a hydroxamic acid functionalized center block that chelates iron to form a stabilized micelle that physically entraps chemotherapeutic drugs in the hydrophobic core. The iron-imparted stability significantly improves the integrity of the micelle and extends circulation pharmacokinetics in plasma over that of free drug. Furthermore, the paramagnetic properties of the iron-crosslinking exhibits contrast in the tumors for imaging by magnetic resonance. Three separate nanoparticle formulations demonstrate improved anti-tumor efficacy in xenograft models and decreased toxicity. We report a stabilized polymer micelle that improves the tolerability and efficacy of chemotherapeutic drugs, and holds potential for non-invasive MRI to image drug delivery and deposition in the tumor.Entities:
Keywords: Chemotherapeutics; Iron-stabilization; MRI agent; Polymer micelle; Targeted delivery
Mesh:
Substances:
Year: 2017 PMID: 28115246 PMCID: PMC5451294 DOI: 10.1016/j.nano.2017.01.009
Source DB: PubMed Journal: Nanomedicine ISSN: 1549-9634 Impact factor: 5.307